Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Precision Medicine Software Market Status and Forecast (2016-2027)
  • 1.3.2 Global Precision Medicine Software Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Precision Medicine Software Supply by Company

• 2.1 Global Precision Medicine Software Sales Value by Company
• 2.2 Precision Medicine Software Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Precision Medicine Software Market Status by Category

• 3.1 Precision Medicine Software Category Introduction
  • 3.1.1 Cloud-based
  • 3.1.2 On-premise
• 3.2 Global Precision Medicine Software Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Precision Medicine Software Market Status by End User/Segment

• 4.1 Precision Medicine Software Segment by End User/Segment
  • 4.1.1 Healthcare Providers
  • 4.1.2 Pharmaceutical and Biotechnology Companies
  • 4.1.3 Research Centers and Government Institutes
  • 4.1.4 Others
• 4.2 Global Precision Medicine Software Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Precision Medicine Software Market Status by Region

• 5.1 Global Precision Medicine Software Market by Region
• 5.2 North America Precision Medicine Software Market Status
• 5.3 Europe Precision Medicine Software Market Status
• 5.4 Asia Pacific Precision Medicine Software Market Status
• 5.5 Central & South America Precision Medicine Software Market Status
• 5.6 Middle East & Africa Precision Medicine Software Market Status

6 North America Precision Medicine Software Market Status

• 6.1 North America Precision Medicine Software Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Precision Medicine Software Market Status

• 7.1 Europe Precision Medicine Software Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Precision Medicine Software Market Status

• 8.1 Asia Pacific Precision Medicine Software Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Precision Medicine Software Market Status

• 9.1 Central & South America Precision Medicine Software Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Precision Medicine Software Market Status

• 10.1 Middle East & Africa Precision Medicine Software Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Precision Medicine Software Market Forecast by Category and by End User/Segment

• 12.1 Global Precision Medicine Software Sales Value Forecast (2022-2027)
• 12.2 Global Precision Medicine Software Forecast by Category
• 12.3 Global Precision Medicine Software Forecast by End User/Segment

13 Global Precision Medicine Software Market Forecast by Region/Country

• 13.1 Global Precision Medicine Software Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Translational Software
  • 14.1.1 Company Information
  • 14.1.2 Precision Medicine Software Product Introduction
  • 14.1.3 Translational Software Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Syapse
  • 14.2.1 Company Information
  • 14.2.2 Precision Medicine Software Product Introduction
  • 14.2.3 Syapse Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Sophia Genetics
  • 14.3.1 Company Information
  • 14.3.2 Precision Medicine Software Product Introduction
  • 14.3.3 Sophia Genetics Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Roper Technologies
  • 14.4.1 Company Information
  • 14.4.2 Precision Medicine Software Product Introduction
  • 14.4.3 Roper Technologies Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Qiagen
  • 14.5.1 Company Information
  • 14.5.2 Precision Medicine Software Product Introduction
  • 14.5.3 Qiagen Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 PierianDx
  • 14.6.1 Company Information
  • 14.6.2 Precision Medicine Software Product Introduction
  • 14.6.3 PierianDx Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Lifeomic Health
  • 14.7.1 Company Information
  • 14.7.2 Precision Medicine Software Product Introduction
  • 14.7.3 Lifeomic Health Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Human Longevity
  • 14.8.1 Company Information
  • 14.8.2 Precision Medicine Software Product Introduction
  • 14.8.3 Human Longevity Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Gene42, Inc
  • 14.9.1 Company Information
  • 14.9.2 Precision Medicine Software Product Introduction
  • 14.9.3 Gene42, Inc Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Foundation Medicine
  • 14.10.1 Company Information
  • 14.10.2 Precision Medicine Software Product Introduction
  • 14.10.3 Foundation Medicine Precision Medicine Software Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Fabric Genomics
• 14.12 Allscripts

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Precision Medicine Software market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Precision Medicine Software market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Cloud-based
On-premise

Segmented by End User/Segment
Healthcare Providers
Pharmaceutical and Biotechnology Companies
Research Centers and Government Institutes
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Translational Software
Syapse
Sophia Genetics
Roper Technologies
Qiagen
PierianDx
Lifeomic Health
Human Longevity
Gene42, Inc
Foundation Medicine
Fabric Genomics
Allscripts